Related references
Note: Only part of the references are listed.Post-translational modifications of adiponectin: mechanisms and functional implications
Yu Wang et al.
BIOCHEMICAL JOURNAL (2008)
Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
Weidong Zhu et al.
CLINICAL SCIENCE (2008)
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
K. M. Choi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people
Qibin Qi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation
Gianluca Perseghin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production
Ruby L. C. Hoo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men
Yoshic Seino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance
Qing-Wu Yan et al.
DIABETES (2007)
Serum adipocyte fatty acid-binding protein as a new biomarker, predicting the development of type 2 diabetes - A 10-year prospective study in a Chinese cohort
Annette W. K. Tso et al.
DIABETES CARE (2007)
Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease
Gideon R. Hajer et al.
AMERICAN HEART JOURNAL (2007)
Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes
A. Cabre et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women
Ji-Won Lee et al.
OBESITY (2007)
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease
M. von Eynatten et al.
DIABETOLOGIA (2007)
High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease
Teruo Inoue et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis
D. C. Y. Yeung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men
Masayuki Torigoe et al.
CLINICAL ENDOCRINOLOGY (2007)
Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients
J. Raila et al.
KIDNEY INTERNATIONAL (2007)
Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia
M. Karpisek et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Association of serum retinol-binding protein 4 and visceral adiposity in chinese subjects with and without type 2 diabetes
Weiping Jia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adiposity and cardiovascular disorders - Disturbance of the regulatory system consisting of humoral and neuronal signals
Hideki Katagiri et al.
CIRCULATION RESEARCH (2007)
Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone
Aiwei Yao-Borengasser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Retinol binding protein-4 levels and clinical features of type 2 diabetes patients
Kohzo Takebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass
Nora Kloeting et al.
CELL METABOLISM (2007)
Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects
Montserrat Broch et al.
DIABETES CARE (2007)
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi et al.
NATURE (2007)
Hypoadiponectinemia as a predictor for the development of hypertension - A 5-year prospective study
Wing-Sun Chow et al.
HYPERTENSION (2007)
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans
Norbert Stefan et al.
DIABETES CARE (2007)
Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes
Shai Gavi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart
F. Aigner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects
T. E. Graham et al.
DIABETOLOGIA (2007)
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome - A 5-year prospective study
Aimin Xu et al.
CIRCULATION (2007)
Reduced adiponectin level is associated with severity of coronary artery disease
Kazuo Hara et al.
INTERNATIONAL HEART JOURNAL (2007)
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects
Dominik G. Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
Toshimasa Yamauchi et al.
NATURE MEDICINE (2007)
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
Yu Wang et al.
CLINICAL CHEMISTRY (2007)
Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity
D. G. Haider et al.
DIABETES OBESITY & METABOLISM (2007)
Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-κB
De-xiu Bu et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
Young Min Cho et al.
DIABETES CARE (2006)
Retinol-binding protein 4 in human obesity
Juergen Janke et al.
DIABETES (2006)
A novel ELISA system for selective measurement of human adiponectin multimers by using proteases
Hiroyuki Ebinuma et al.
CLINICA CHIMICA ACTA (2006)
Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
D. Stejskal et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study
A. W. K. Tso et al.
DIABETOLOGIA (2006)
A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin
Yasuko Nakano et al.
JOURNAL OF LIPID RESEARCH (2006)
Comparison of serum high-molecular weight (HMS adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin
Yoshimasa Aso et al.
DIABETES (2006)
Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice
Haiming Cao et al.
DIABETES (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adiponectin replenishment ameliorates obesity-related hypertension
Koji Ohashi et al.
HYPERTENSION (2006)
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
G Tuncman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice
AV Hertzel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men
K Matsushita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome
Kazuo Hara et al.
DIABETES CARE (2006)
Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction
AL Hemdahl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2 dependent mechanisms
R Shibata et al.
NATURE MEDICINE (2005)
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
C Kistorp et al.
CIRCULATION (2005)
Changes of adiponectin oligomer composition by moderate weight reduction
T Bobbert et al.
DIABETES (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males
FM Fisher et al.
DIABETOLOGIA (2005)
Association of low adiponectin levels with the metabolic syndrome - the Chennai Urban Rural Epidemiology Study (CURES-4)
V Mohan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
The common polymorphisms (single nucleotide polymorphism, [SNP]+45 and SNP+276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes - The STOP-NIDDM trial
J Zacharova et al.
DIABETES (2005)
Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-κB activation
A Planavila et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
AM McNeill et al.
DIABETES CARE (2005)
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes
K Maeda et al.
CELL METABOLISM (2005)
Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice
RA Baar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Plasma adiponectin levels and risk of myocardial infarction in men
T Pischon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Adiponectin gene polymorphisms and adiponectin levels are indedendently associated with the development of hyperglycemia during a 3-year period -: The Epidemiologic Data on the Insulin Resistance Syndrome prospective study
F Fumeron et al.
DIABETES (2004)
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin
H Kobayashi et al.
CIRCULATION RESEARCH (2004)
Association of the human adiponectin gene and insulin resistance
E Filippi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation
KCB Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin and the development of type 2 diabetes - The atherosclerosis risk in communities study
BB Duncan et al.
DIABETES (2004)
Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans
KM Choi et al.
CLINICAL ENDOCRINOLOGY (2004)
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity
TP Combs et al.
ENDOCRINOLOGY (2004)
Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: Two-year follow-up study in Japanese population
Y Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin as a biomarker of the metabolic syndrome
M Ryo et al.
CIRCULATION JOURNAL (2004)
Hypoadiponectinemia is an independent risk factor for hypertension
Y Iwashima et al.
HYPERTENSION (2004)
Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages
G Llaverias et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Association of hypoadiponectinemia with impaired vasoreactivity
N Ouchi et al.
HYPERTENSION (2003)
Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity
WS Yang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism
N Pannacciulli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Role of the fatty acid binding protein mal1 in obesity and insulin resistance
K Maeda et al.
DIABETES (2003)
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
T Yamauchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adiponectin and protection against type 2 diabetes mellitus
J Spranger et al.
LANCET (2003)
Association of hypoadiponectinemia with coronary artery disease in men
M Kumada et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
HM Lakka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice
Y Okamoto et al.
CIRCULATION (2002)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Disruption of adiponectin causes insulin resistance and neointimal formation.
N Kubota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Adiponectin and development of type 2 diabetes in the Pima Indian population
RS Lindsay et al.
LANCET (2002)
A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
C Menzaghi et al.
DIABETES (2002)
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
N Maeda et al.
NATURE MEDICINE (2002)
Association of adiponectin mutation with type 2 diabetes - A candidate gene for the insulin resistance syndrome
H Kondo et al.
DIABETES (2002)
Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population
K Hara et al.
DIABETES (2002)
Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity - Interaction with family history of type 2 diabetes
M Stumvoll et al.
DIABETES (2002)
Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q
C Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski et al.
NATURE MEDICINE (2001)
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
J Fruebis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Adipose tissue as an endocrine organ
RS Ahima et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway
N Ouchi et al.
CIRCULATION (2000)
Improved glucose and lipid metabolism in genetically obese mice lacking aP2
KT Uysal et al.
ENDOCRINOLOGY (2000)
Share Paper
